{
    "titel": [
        "Stada Arzneimittel AG"
    ],
    "Tipe": [
        "Aktiengesellschaft"
    ],
    "Gehandel as": [
        "FWB: SAZ"
    ],
    "Industrie": [
        "Pharmaceuticals"
    ],
    "Gesloon": [
        "Dresden, 1895"
    ],
    "Si\u00e8ge": [
        "Bad Vilbel, Duitsland"
    ],
    "Sleutelspeakers": [
        "Peter Goldschmidt CEO",
        "G\u00fcnter von Au (Chairman van die supervisory board)"
    ],
    "Produkte": [
        "Generiese en onthe-counter drugs"
    ],
    "Inkomens": [
        "2. 33 miljard euro (2018)"
    ],
    "Operating inkomen": [
        "\u20ac 378.1 miljoen (2018)"
    ],
    "Net inkomen": [
        "306,9 miljoen euro (2018)"
    ],
    "Totaal aktien": [
        "3, 335 miljard euro (end 2014)"
    ],
    "Totaal kapitaal": [
        "\u20ac 903.3 miljoen ( einde 2014)"
    ],
    "Nommer van werknemers": [
        "10, 416 (FTE, gemiddelde 2018)"
    ],
    "Webruimte": [
        "www.stada.com"
    ]
}